Form 4: CFO LeBlanc Reports LMAT Stock Transactions

Lemaitre Vascular CFO Dorian Paul LeBlanc reported the acquisition of 2 shares and the disposition of 96 shares for tax withholding related to RSU vesting.

Summary

• Dorian Paul LeBlanc, Chief Financial Officer of Lemaitre Vascular Inc. (LMAT), reported transactions involving the company's common stock.
• On March 10, 2026, LeBlanc acquired 2 shares of common stock upon the release of dividend equivalent rights, which were connected to the vesting of a restricted stock unit (RSU) award granted on March 10, 2025.
• On the same date, LeBlanc disposed of 96 shares of common stock at a price of $109.2 per share.
• This disposition was specifically to satisfy tax withholding obligations incurred upon the vesting of the aforementioned restricted stock units.
• Following these reported transactions, LeBlanc directly beneficially owns 2,302 shares of common stock and 9.3269 dividend equivalent rights.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing routine compensation-related transactions for a corporate officer, with no significant positive or negative implications for the company's operations or strategy.

Positives

• The vesting of restricted stock units and dividend equivalent rights indicates continued employment and alignment of the CFO's interests with shareholders.
• The acquisition of 2 shares from dividend equivalent rights adds to the CFO's direct ownership.

Negatives

• The disposition of 96 shares, while for tax purposes, results in a reduction of the CFO's direct common stock ownership.

Industry Context

StockSavvy.ai notes that routine Form 4 filings, such as this one, are common disclosures for corporate officers and typically reflect compensation-related activities rather than discretionary trading, providing transparency into executive stock ownership changes.

Related Party Transactions

• The transactions involve the company's Chief Financial Officer and the company itself, related to executive compensation (restricted stock unit vesting and associated tax withholding).

Stakeholder Impact

• Shareholders: Minimal direct impact, as these are routine compensation disclosures and do not reflect discretionary trading or a change in company fundamentals.
• Employees: Reflects standard executive compensation practices, which can be a benchmark for other employees with similar equity awards.

Key Dates

Recommendation

This Form 4 filing details routine, non-discretionary transactions by a corporate officer related to compensation. It does not provide new information about the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. The transactions are expected and do not signal any material shift in the company's prospects.

Keywords

Lemaitre Vascular, LMAT, Form 4, insider transaction, CFO, Dorian Paul LeBlanc, restricted stock units, RSU, dividend equivalent rights, tax withholding